Lung diseases
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
700
|
50
|
0.300 |
limited |
|
0 |
|
|
|
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
3
|
0.300 |
None |
|
0 |
|
|
|
Pulmonary Hypertension, Primary, Fenfluramine-Associated
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
|
0.300 |
None |
|
0 |
|
|
|
Pulmonary Hypertension, Primary, 1
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
9
|
323
|
0.300 |
None |
|
0 |
|
|
|
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
1
|
0.300 |
None |
|
0 |
|
|
|
Increased pulmonary vascular resistance
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
2-oxo-hept-3-ene-1,7-dioate hydratase activity
|
phenotype |
|
Molecular Function
|
14
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hamartomatous polyposis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Disease or Syndrome
|
23
|
3
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Familial pulmonary arterial hypertension
|
disease |
|
Disease or Syndrome
|
12
|
1
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Pulmonary arterial hypertension associated with congenital heart disease
|
disease |
|
Disease or Syndrome
|
5
|
11
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Bone Density
|
phenotype |
|
Clinical Attribute
|
138
|
654
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Adenoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
452
|
213
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Associated Pulmonary Arterial Hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
22
|
4
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Benign Prostatic Hyperplasia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
770
|
91
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Cystic echinococcosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms; Infections
|
Disease or Syndrome
|
43
|
2
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Osteoporosis
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
1098
|
182
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
1183
|
103
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Iron Overload
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
241
|
53
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Fibrosis, Liver
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
1179
|
64
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |